Severe sepsis and septic shock are life-threatening conditions with a very high mortality rate. Severe sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection criteria. Septic shock is defined as a state of acute circulatory failure characterized by persistent arterial hypotension that cannot be successfully rescued by fluid resuscitation criteria. A constellation of clinical, laboratory, physiologic, and microbiologic data is required for the diagnosis of severe sepsis and septic shock.
The publisher epidemiologists used age- and sex-specific diagnosed incidence rates to forecast the diagnosed incident cases, taking into account the significant relationship between age and Severe sepsis. The publisher epidemiologists applied country-specific incidence rates of severe sepsis and septic shock wherever available, to each country’s population to obtain the number of estimated diagnosed incident cases.
The following data describes epidemiology of severe sepsis and septic shock cases. In 2020, the 7MM had 2,344,143 diagnosed incident cases of severe sepsis. This is expected to increase to 2,794,568 diagnosed incident cases by 2030, at an Annual Growth Rate (AGR) of 1.92%. In the 7MM, the diagnosed incident cases of septic shock will increase from 559,513 cases in 2020 to 664,991 cases in 2030, at an AGR of 1.89%. This increase is partly attributed to the moderately rising trend in incidence in the 7MM, combined with underlying demographic changes in the respective markets. The early diagnosis and development of more effective therapies would improve survival from severe sepsis and septic shock.
The publisher epidemiologists used age- and sex-specific diagnosed incidence rates to forecast the diagnosed incident cases, taking into account the significant relationship between age and Severe sepsis. The publisher epidemiologists applied country-specific incidence rates of severe sepsis and septic shock wherever available, to each country’s population to obtain the number of estimated diagnosed incident cases.
The following data describes epidemiology of severe sepsis and septic shock cases. In 2020, the 7MM had 2,344,143 diagnosed incident cases of severe sepsis. This is expected to increase to 2,794,568 diagnosed incident cases by 2030, at an Annual Growth Rate (AGR) of 1.92%. In the 7MM, the diagnosed incident cases of septic shock will increase from 559,513 cases in 2020 to 664,991 cases in 2030, at an AGR of 1.89%. This increase is partly attributed to the moderately rising trend in incidence in the 7MM, combined with underlying demographic changes in the respective markets. The early diagnosis and development of more effective therapies would improve survival from severe sepsis and septic shock.
Scope
- Severe Sepsis and Septic Shock Epidemiology Report provides an overview of the risk factors and global trends of severe sepsis and septic shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- This report also includes a 10-year epidemiological forecast for the following segmentations in all ages across the 7MM: diagnosed incident cases of severe sepsis, and septic shock. Diagnosed incident cases of severe sepsis and septic shock are further segmented by causative agents and organ dysfunction. Additionally, the publisher epidemiologists provide a forecast for the in-hospital mortality cases of severe sepsis and septic shock.
- The Severe Sepsis and Septic Shock Epidemiology Report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to Buy
The Severe Sepsis and Septic Shock epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global severe sepsis and septic shock market.
- Quantify patient populations in the global severe sepsis and septic shock market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the causative agents that present the best opportunities for therapeutics in each of the markets covered.
- Understand magnitude of organ dysfunction in severe sepsis and septic shock in these markets.
Table of Contents
1 Severe Sepsis and Septic Shock: Executive Summary
2 Epidemiology
3 Appendix
List of Tables
List of Figures
